Janus Henderson Group PLC Purchases 6,922 Shares of Select Medical Holdings Co. (NYSE:SEM)

Janus Henderson Group PLC grew its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 14.7% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 54,021 shares of the health services provider’s stock after acquiring an additional 6,922 shares during the quarter. Janus Henderson Group PLC’s holdings in Select Medical were worth $1,883,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Transcendent Capital Group LLC bought a new position in shares of Select Medical during the 2nd quarter valued at $35,000. Canada Pension Plan Investment Board purchased a new stake in shares of Select Medical in the 2nd quarter worth $39,000. DekaBank Deutsche Girozentrale purchased a new stake in shares of Select Medical in the 2nd quarter worth $60,000. GAMMA Investing LLC increased its stake in shares of Select Medical by 16.6% in the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock worth $81,000 after purchasing an additional 330 shares in the last quarter. Finally, Innealta Capital LLC purchased a new stake in shares of Select Medical in the 2nd quarter worth $117,000. 89.48% of the stock is owned by institutional investors.

Select Medical Trading Up 0.8 %

Shares of SEM stock opened at $19.83 on Friday. Select Medical Holdings Co. has a 52-week low of $19.52 and a 52-week high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The firm has a market capitalization of $2.57 billion, a PE ratio of 9.27, a PEG ratio of 0.40 and a beta of 1.43. The stock has a fifty day simple moving average of $31.53 and a two-hundred day simple moving average of $33.85.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. Select Medical’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.46 EPS. On average, analysts predict that Select Medical Holdings Co. will post 1.97 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were given a dividend of $0.125 per share. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.52%. Select Medical’s payout ratio is 23.36%.

Insider Activity

In other news, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 17.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, December 3rd. Royal Bank of Canada upped their price objective on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Bank of America initiated coverage on Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective for the company. Finally, Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.